Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 30;12(13):4403.
doi: 10.3390/jcm12134403.

Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study

Jue T Wang  1 , Samir C Seshadri  1 , Carolyn G Butler  1 , Steven J Staffa  1 , Anna S Kordun  1 , Karina E Lukovits  1 , Susan M Goobie  1
Affiliations

Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study

Jue T Wang et al. J Clin Med. .

Abstract

Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is recommended for major pediatric surgery to decrease perioperative blood loss. Accumulating evidence suggests that TXA reduces bleeding and transfusion in a variety of adult neurosurgical settings. However, there is a paucity of research regarding TXA indications for pediatric neurosurgery and thus, there are currently no recommendations for its use with this specific population. The objective of this study is to evaluate the existing practice of TXA administration for pediatric neurosurgery at a U.S. tertiary care pediatric hospital over a five-year period. The authors conclude that TXA administration is feasible and should be considered for pediatric neurosurgical cases where potential blood loss is a concern.

Keywords: antifibrinolytics; blood loss; neurosurgery; patient blood management (PBM); pediatrics; tranexamic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Goobie S.M., Haas T. Perioperative bleeding management in pediatric patients. Curr. Opin. Anaesthesiol. 2016;29:352–358. doi: 10.1097/ACO.0000000000000308. - DOI - PubMed
    1. Faraoni D., Goobie S.M. The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: A systematic review of the literature. Anesth. Analg. 2014;118:628–636. doi: 10.1213/ANE.0000000000000080. - DOI - PubMed
    1. Tzortzopoulou A., Cepeda M.S., Schumann R., Carr D.B. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst. Rev. 2008;9:CD006883. doi: 10.1002/14651858.CD006883.pub2. - DOI - PubMed
    1. Patel P.A., Wyrobek J.A., Butwick A.J., Pivalizza E.G., Hare G.M.T., Mazer C.D., Goobie S.M. Update on Applications and Limitations of Perioperative Tranexamic Acid. Anesth. Analg. 2022;135:460–473. doi: 10.1213/ANE.0000000000006039. - DOI - PubMed
    1. King M.R., Staffa S.J., Stricker P.A., Pérez-Pradilla C., Nelson O., Benzon H.A., Goobie S.M., Abruzzese C., Asmal I., Bailey K., et al. Safety of antifibrinolytics in 6583 pediatric patients having craniosynostosis surgery: A decade of data reported from the multicenter Pediatric Craniofacial Collaborative Group. Pediatr. Anesth. 2022;32:1339–1346. doi: 10.1111/pan.14540. - DOI - PubMed

LinkOut - more resources